Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with ...

Morphic Therapeutic has lost Johnson & Johnson's Janssen Pharma as a partner, following the termination of an alliance to develop drugs targeting integrins first agreed in 2019. In a filing with ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. has announced a daily update on its ongoing buy-back program, with 30,232 ordinary fully paid ...

Eli Lilly has bolstered its inflammatory bowel disease (IBD) pipeline with a $3.2 billion bid to acquire Morphic and its mid-stage oral integrin therapy MORF-057. Lilly is launching a tender offer ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update. Morphic Ethical Equities Fund Ltd. has updated its ongoing buy-back of ordinary fully paid securities with a recent purchase of ...

The American pharmaceutical company Eli Lilly & Co. has entered into an agreement to acquire the biopharmaceutical company Morphic Holding Inc. This is reported in a press release Eli Lilly. The ...

Morphic Ethical Equities Fund Ltd. (AU:MEC) has released an update.Don't Miss our Black Friday Offers:Unlock your investing potential with ...

Investing in global listed securities screened to exclude entities involved in environmentally damaging activities (including coal and uranium, mining and oil and gas), intensive farming and ...

Dr. Tipirneni most recently served as President and CEO of Morphic Therapeutics Inc. from company founding until the ...